You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MCL1

Showing 26 - 50 of 694
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

Completed
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
Nov 14, 2022

Sarcoma, Melanoma, Lung Cancer Trial in United States (PRT1419)

Recruiting
  • Sarcoma
  • +6 more
  • Denver, Colorado
  • +6 more
May 26, 2022

Multiple Myeloma (MM), Cancer Trial in Worldwide (ABBV-467)

Terminated
  • Multiple Myeloma (MM)
  • Cancer
  • Tucson, Arizona
  • +23 more
Jul 20, 2021

Non-Hodgkin Lymphoma (NHL), Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial in Worldwide (VOB560, MIK665)

Recruiting
  • Non-Hodgkin Lymphoma (NHL)
  • +2 more
  • Gent, Belgium
  • +9 more
Mar 18, 2022

Lymphoma, Mantle-Cell Trial in Stanford (biological, procedure, drug)

Completed
Has Results
  • Lymphoma, Mantle-Cell
  • CpG-MCL vaccine
  • +7 more
  • Stanford, California
    Stanford University Medical Center
Jan 8, 2020

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Blood and Bone Marrow Samples From Previously Untreated Chronic

Completed
  • Leukemia
  • fluorescence in situ hybridization
  • +6 more
  • San Diego, California
  • +34 more
Aug 2, 2022

Acute Monocytic Leukemia, Newly Diagnosed Trial in Suzhou (Chidamide, Azacitidine, Venetoclax)

Recruiting
  • Acute Monocytic Leukemia
  • Newly Diagnosed
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Oct 3, 2022

Allergy to Cats Trial (Zafirlukast)

Not yet recruiting
  • Allergy to Cats
  • (no location specified)
Sep 29, 2023

Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib, Ibrutinib, Acalabrutinib)

Recruiting
  • Lymphoma, Mantle-Cell
  • Phoenix, Arizona
  • +158 more
Aug 15, 2022

Metastatic Malignant Solid Tumor, Recurrent Lung Small Cell Carcinoma, Recurrent Malignant Solid Tumor Trial in United States

Terminated
  • Metastatic Malignant Solid Neoplasm
  • +8 more
  • Los Angeles, California
  • +13 more
Oct 7, 2022

Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

Not yet recruiting
  • Mantle Cell Lymphoma Refractory
  • (no location specified)
May 16, 2023

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting
  • Relapsed or Refractory Lymphomas
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Nov 9, 2023

Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL) Trial in

Recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • +5 more
  • WZTL002-1 (1928T2z CAR-T cells)
  • Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
  • Wellington, New Zealand
    Wellington Hospital, Capital & Coast District Health Board
Feb 18, 2020

Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

Recruiting
  • Lymphoma
  • +4 more
  • Vysis LSI MYC Break Apart Rearrangement Probe Kit
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting
  • Metastatic Endometrial Carcinoma
  • +7 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Mantle Cell Lymphoma Trial in Duarte (drug, procedure, biological)

Not yet recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

Terminated
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma
  • Saint Louis, Missouri
  • +1 more
Jan 18, 2023

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

Recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

The Role of 18F-FDG-PET for Staging and Prognostication

Recruiting
  • Mantle Cell Lymphoma
    • Reggio Calabria, Calabria, Italy
    • +30 more
    Dec 5, 2022

    Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

    Recruiting
    • Recurrent AL Amyloidosis
    • Refractory AL Amyloidosis
    • Biospecimen Collection
    • +9 more
    • Duarte, California
    • +10 more
    Jan 19, 2023

    A Disease Registry of Patients With Mantle Cell Lymphoma

    Active, not recruiting
    • Mantle Cell Lymphoma
      • Montgomery, Alabama
      • +33 more
      Oct 28, 2022

      B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

      Not yet recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • (no location specified)
      Mar 6, 2023

      Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

      Completed
      • Acute Lymphoblastic Leukemia
      • San Francisco, California
      • +7 more
      Aug 5, 2022